These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20094929)

  • 1. Data safety monitoring boards: legal and ethical considerations for research accountability.
    Tereskerz PM
    Account Res; 2010 Jan; 17(1):30-50. PubMed ID: 20094929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An opinion and practice survey on the structure and management of data and safety monitoring boards.
    Tereskerz PM; Guterbock TM; Kermer DA; Moreno JD
    Account Res; 2011 Jan; 18(1):1-30. PubMed ID: 21287412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data and safety monitoring policy for National Institute of Allergy and Infectious Diseases clinical trials.
    Dixon DO; Weiss S; Cahill K; Fox L; Love J; McNamara J; Soto-Torres LE
    Clin Trials; 2011 Dec; 8(6):727-35. PubMed ID: 22024105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data safety and monitoring boards for African clinical trials.
    Lang T; Chilengi R; Noor RA; Ogutu B; Todd JE; Kilama WL; Targett GA
    Trans R Soc Trop Med Hyg; 2008 Dec; 102(12):1189-94. PubMed ID: 18644610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of litigation in human research accountability.
    De Ville K
    Account Res; 2002; 9(1):17-43. PubMed ID: 12705245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of escalating regulatory requirements on the conduct of clinical research.
    Gordon BG; Kessinger A; Mann SL; Prentice ED
    Cytotherapy; 2003; 5(4):309-13. PubMed ID: 12944237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Building a more connected DSMB: better integrating ethics review and safety monitoring.
    Eckstein L
    Account Res; 2015; 22(2):81-105. PubMed ID: 25397600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-based interventions for neurologic conditions: ethical challenges for early human trials.
    Mathews DJ; Sugarman J; Bok H; Blass DM; Coyle JT; Duggan P; Finkel J; Greely HT; Hillis A; Hoke A; Johnson R; Johnston M; Kahn J; Kerr D; Kurtzberg J; Liao SM; McDonald JW; McKhann G; Nelson KB; Rao M; Regenberg A; Siegel AW; Smith K; Solter D; Song H; Vescovi A; Young W; Gearhart JD; Faden R
    Neurology; 2008 Jul; 71(4):288-93. PubMed ID: 18463365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research and legal liability.
    Singh JA
    Acta Trop; 2009 Nov; 112 Suppl 1():S71-5. PubMed ID: 19665438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continued concern: human subject protection, the institutional review board, and continuing review.
    Hoffman S
    Tenn Law Rev; 2001; 68(4):725-70. PubMed ID: 16189912
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.
    Wittes J; Barrett-Connor E; Braunwald E; Chesney M; Cohen HJ; Demets D; Dunn L; Dwyer J; Heaney RP; Vogel V; Walters L; Yusuf S
    Clin Trials; 2007; 4(3):218-34. PubMed ID: 17715247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liability issues for data monitoring committee members.
    DeMets DL; Fleming TR; Rockhold F; Massie B; Merchant T; Meisel A; Mishkin B; Wittes J; Stump D; Califf R
    Clin Trials; 2004; 1(6):525-31. PubMed ID: 16279293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast track to disaster? Considerations raised by the current recruitment techniques for clinical research subjects.
    Isidor JM; Kaltman SP
    J Biolaw Bus; 2002; 5(3):46-7. PubMed ID: 12816118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical considerations in conducting pediatric research.
    Roth-Cline M; Gerson J; Bright P; Lee CS; Nelson RM
    Handb Exp Pharmacol; 2011; 205():219-44. PubMed ID: 21882114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A legal duty to disclose individual research findings to research subjects?
    Gordon MP
    Food Drug Law J; 2009; 64(1):225-60. PubMed ID: 19998747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioethical malpractice: risk and responsibilities in human research.
    Noah BA
    J Health Care Law Policy; 2004; 7(2):175-241. PubMed ID: 15573441
    [No Abstract]   [Full Text] [Related]  

  • 17. New guidance on reviews by central institutional review boards (IRBs).
    Maloney DM
    Hum Res Rep; 2005 May; 20(5):1-2. PubMed ID: 16175714
    [No Abstract]   [Full Text] [Related]  

  • 18. Investigator financial disclosures and its effect on research subjects.
    Gibbs JN; Guagnano GA
    Food Drug Law J; 2007; 62(4):727-37. PubMed ID: 18557228
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trials litigation: practical realities as seen from the trenches.
    Morreim EH
    Account Res; 2005; 12(1):47-67. PubMed ID: 16021792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disclosing clinical trial results: publicity, significance and independence.
    Liao SM; Sheehan M; Clarke S
    Am J Bioeth; 2009 Aug; 9(8):W3-5. PubMed ID: 19998144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.